BioMed Central issued a press release today announcing the addition of the Beilstein Journal of Organic Chemistry (BJOC) to PubMed Central.
The Beilstein Journal of Organic Chemistry (BJOC) is now included in PubMed Central, the world's largest digital archive of freely available full-text journal literature. PubMed Central hosts over 200 journals, mainly in the life sciences and medicine. BJOC is one of the first chemistry journals to be accepted for inclusion in the database, which will bring its articles to the attention of an enormous worldwide readership of biomedical scientists.
BJOC is published by the Beilstein-Institut, a name synonymous with quality in organic chemistry for two centuries, in co-operation with BioMed Central, the leading global publisher of open access journals. As one of the first open access journals in chemistry, BJOC allows readers free access to all content immediately upon publication. BJOC has no publication charges, is fully refereed and offers rapid publication. Authors may submit their articles online to the Editor-in-Chief, Professor Jonathan Clayden of the University of Manchester, UK. (www.beilstein-journals.org/BJOC).
Dr Martin Hicks, Director of the Beilstein-Institut, said 'Our objective in publishing BJOC is to serve organic chemists worldwide by providing a high quality journal that serves their needs as authors and readers, without being a financial burden to their institutes. We are delighted that inclusion in PubMed Central will bring the high quality articles published in BJOC to the attention of the growing number of biomedical researchers with an interest in organic chemistry and chemical biology.'
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
